Evidence map›Paper›PMID 16051857›Full record

ArticleJournal of virology2005

Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1.

Kasia Hrecka, Tomek Swigut, Michael Schindler, Frank Kirchhoff, Jacek Skowronski

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Review
  3. Viral Coinfections.Viruses · 2022
    Review
  4. Review
  5. Article
  6. Virological and Immunological Outcomes of Coinfections.Clinical microbiology reviews · 2018
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Kasia HreckaCold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
Tomek Swigut
Michael Schindler
Frank Kirchhoff
Jacek Skowronski
Cold Spring Harbor Laboratory · USUniversität Ulm · DE

Funding

MOLECULAR INTERACTIONS OF NEF AND AIDS PATHOGENESISR01AI042561 · NIAID · COLD SPRING HARBOR LABORATORY · PI SKOWRONSKI, JACEK · 1998 to 2007
$4.7M
NIAID NIH HHS AI-42561NIAID NIH HHS R01 AI042561
6 · The paper itself

Abstract

Nef proteins of primate lentiviruses promote viral replication, virion infectivity, and evasion of antiviral immune responses by modulating signal transduction pathways and downregulating expression of receptors at the cell surface that are important for efficient antigen-specific responses, such as CD4, CD28, T-cell antigen receptor, and class I and class II major histocompatibility complex. Here we show that Nef proteins from diverse groups of primate lentiviruses which do not require the chemokine receptor CXCR4 for entry into target cells strongly downmodulate the cell surface expression of CXCR4. In contrast, all human immunodeficiency virus type 1 (HIV-1) and the majority of HIV-2 Nef proteins tested did not have such strong effects. SIVmac239 Nef strongly inhibited lymphocyte migration to CXCR4 ligand, the chemokine stromal derived factor 1 (SDF-1). SIVmac239 Nef downregulated CXCR4 by accelerating the rate of its endocytosis. Downmodulation of CXCR4 was abolished by mutations that disrupt the constitutively strong AP-2 clathrin adaptor binding element located in the N-terminal region of the Nef molecule, suggesting that Nef accelerates CXCR4 endocytosis via an AP-2-dependent pathway. Together, these results point to CXCR4 as playing an important role in simian immunodeficiency virus and possibly also HIV-2 persistence in vivo that is unrelated to viral entry into target cells. We speculate that Nef targets CXCR4 to disrupt ordered trafficking of infected leukocytes between local microenvironments in order to facilitate their dissemination and/or impair the antiviral immune response.

Indexed as

CD4 AntigensCell MovementChemokine CXCL12Chemokines, CXCDown-RegulationEndocytosisGene Products, nefHIVHumansJurkat Cellsnef Gene Products, Human Immunodeficiency VirusReceptors, CXCR4Simian Immunodeficiency VirusT-LymphocytesCD4 AntigensChemokine CXCL12Chemokines, CXCCXCL12 protein, humanGene Products, nefnef Gene Products, Human Immunodeficiency VirusReceptors, CXCR4

Identifiers

PMID16051857
PMCPMC1182621
OpenAlexW2127930176

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.